CRONUS PHARMA LLC, Cephalexin Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Cephalexin from India and how much does CRONUS PHARMA LLC, import?

India exports Cephalexin to 516 buyers globally worth $44.7M. CRONUS PHARMA LLC, imports $1.2M (0.4% market share) with 31 shipments from UNITED STATES.

Q: What is the average order value for CRONUS PHARMA LLC,'s Cephalexin imports?

CRONUS PHARMA LLC,'s average Cephalexin order value is $37.9K per consignment, based on 31 shipments totaling $1.2M.

Q: Who supplies Cephalexin to CRONUS PHARMA LLC,?

CRONUS PHARMA LLC, sources Cephalexin from 1 verified supplier: AUROBINDO PHARMA LIMITED ($1.2M, 100.0%). Based on 31 customs records.

Q: How does CRONUS PHARMA LLC, compare to other Cephalexin importers?

CRONUS PHARMA LLC, ranks #11 among 516 Cephalexin importers from India with 0.4% market share and 31 shipments.

Q: Who are the top Cephalexin importers from India?

Top Cephalexin importers: ASCEND LABORATORIES,LLC ($13.3M), ASCEND LABORATORIES LLC ($9.5M), BREATHEFREE LANKA PVT LTD ($6.8M), M/S. SUN PHARMA ANZ PTY LTD ($3.8M), MORAF PHARMACEUTICALS LIMITED ($1.7M).

Suresh Sormare

Cephalexin

India Pharmaceutical Trade Intelligence

$349.5M223 Suppliers104 CountriesHS 30042012

ExportsIndia → UNITED STATES82.2%India → SRI LANKA5.2%

ImportsUNITED STATES → India$146.5K CROATIA → India$17.9K

#1 Supplier: ALKEM LABORATORIES #1 Buyer: ASCEND LABORATORIES,

CRONUS PHARMA LLC, — Cephalexin Importer #11 | $1.2M Trade Value | TransData Nexus | TransData Nexus

CRONUS PHARMA LLC, — Cephalexin Importer Profile

Pharmaceutical Importer · #11 buyer for Cephalexin · $1.2M import value · 31 shipments · UNITED STATES · DGFT Verified

CRONUS PHARMA LLC, is the #11 importer of Cephalexin from India with $1.2M in import value and 31 verified shipments. CRONUS PHARMA LLC, holds a 0.4% market share in Cephalexin imports based in UNITED STATES. The company sources from 1 verified supplier across 18 formulations shipped to 1 country. Overall, CRONUS PHARMA LLC, imports 2 pharmaceutical products worth $5.5M across 2 therapeutic categories.

CRONUS PHARMA LLC, — Cephalexin Import Profile: Suppliers, Formulations & Sources

CRONUS PHARMA LLC, — Cephalexin import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Cephalexin to CRONUS PHARMA LLC,?

Verified from 31 customs shipment records

Supplier	Value	Shipments	% Share
AUROBINDO PHARMA LIMITED	$1.2M	31	100.0%

CRONUS PHARMA LLC, sources Cephalexin from 1 verified Indian supplier based on 31 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.

How Does CRONUS PHARMA LLC, Compare to Nearest Cephalexin Importers?

Buyers ranked immediately above and below #11 by import value

#	Buyer	Country

Where Does CRONUS PHARMA LLC, Import Cephalexin To?

Destination countries from 31 verified shipments

Country	Value	Shipments	Share
UNITED STATES	$1.2M	31	100.0%

CRONUS PHARMA LLC, imports Cephalexin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.2M.

What Cephalexin Formulations Does CRONUS PHARMA LLC, Import?

Formulation	Value	Shipments
CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) (6941 X 500'S PACKS =3470500 NOS)NOS	$150.0K	3
CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) (6956 X 500'S PACKS =3478000 NOS)NOS	$150.0K	3
CEPHALEXIN CAPSULES USP 500MG (5814 X 500'S PACK)	$140.5K	3
CEPHALEXIN CAPSULES 500MG	$100.0K	2
CEPHALEXIN CAPSULES 250MG (CEPHALEXIN CAPSULES USP 250 MG) (4649 X 500'S PACKS =2324500 NOS)NOS	$67.8K	3
CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) (2313 X 500'S PACKS =1156500 NOS)NOS	$63.1K	3
CEPHALEXIN CAPSULES USP 250 MG (500'S) (	$50.0K	1
CEPHALEXIN CAPSULES USP 500 MG (500'S) (	$50.0K	1
CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) 500'S (4651X500'S PACKS=2325500 NOS )	$50.0K	1
CEPHALEXIN CAPSULES 500MG(CEPHALEXIN CAPSULES USP 500 MG)(QTY:3060 PAK 1530000 EACH)	$50.0K	1

CRONUS PHARMA LLC, imports 18 distinct Cephalexin formulations from India. The top formulation is CEPHALEXIN CAPSULES 500MG (CEPHALEXIN CAPSULES USP 500 MG) ( with 3 shipments worth $150.0K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cephalexin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: CRONUS PHARMA LLC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as CRONUS PHARMA LLC,'s capped import value divided by total capped export value for Cephalexin across all Indian exporters.
5.Verified Records: This page is backed by 31 individual customs records matching CRONUS PHARMA LLC, importing Cephalexin, covering 18 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 516+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cephalexin

Cephalexin

CRONUS PHARMA LLC, — Cephalexin Importer Profile

CRONUS PHARMA LLC, — Cephalexin Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Cephalexin to CRONUS PHARMA LLC,?

How Does CRONUS PHARMA LLC, Compare to Nearest Cephalexin Importers?

Where Does CRONUS PHARMA LLC, Import Cephalexin To?

What Cephalexin Formulations Does CRONUS PHARMA LLC, Import?

Regulatory Requirements: Importing Cephalexin into United States

Regulatory Authority

Approval Process for Generic Cephalexin

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Cephalexin from India and How Much Does CRONUS PHARMA LLC, Import?

What Is the Average Order Value for CRONUS PHARMA LLC,'s Cephalexin Imports?

Who Supplies Cephalexin to CRONUS PHARMA LLC,?

How Does CRONUS PHARMA LLC, Compare to Other Cephalexin Importers?

About CRONUS PHARMA LLC,

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cephalexin Import Data for CRONUS PHARMA LLC,

CRONUS PHARMA LLC, × Cephalexin

Company Overview

Top Products by CRONUS PHARMA LLC,

Related Analysis

Need Detailed Import Data?

Data Source

13	MORAF PHARMACEUTICALS LIMITED	TANZANIA	$1.7M	40	$42.5K
10	M S SUN PHARMA ANZ PTY LIMITED	AUSTRALIA	$1.6M	33	$50.0K
11	CRONUS PHARMA LLC, ★	UNITED STATES	$1.6M	31	$50.0K
12	CRONUS PHARMA LLC ★	UNITED STATES	$1.4M	29	$50.0K
17	SIVEM PHARMACEUTICALS	UNITED STATES	$1.3M	28	$47.8K